PipelinePharma Logo
PipelinePharma Logo

CTD Dossier Marketplace

Direct connection with CTD dossier (IP) owners and manufacturers

Marketing Authorizations Database

Search across marketing authorization registers
Sign in Get started

Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Ciprofibrate manufacturers

Filters

None products found

ciprofibrate

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #36197

Established in 2018, this manufacturer specializes in exporting and manufacturing pharmaceutical active pharmaceutical ingredients (APIs) and finished formulations, including tablets, capsules, pre-filled syringes, dry syrups, creams, ointments, injectables (liquids and powder), eye/ear drops, IV fluids, and surgical products. As a CTD dossier owner and manufacturer, it holds EU/WHO GMP certifications, ensuring compliance with international quality standards. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across various regions, including Central America, non-EU Europe, the Middle East, Oceania, South America, and South Asia.

Manufacturer usually replies in 81 days

ciprofibrate

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18722
This pharmaceutical manufacturer boasts decades of experience in the industry, providing a broad range of affordable finished formulations, including prescription drugs, OTC medications, and supplements. They offer turnkey manufacturing, technology transfer, contract development and manufacturing services, as well as co-development and co-marketing options. Key therapy areas include chronic and acute therapies, OTCs, and complex formulations. Dosage forms include tablets, capsules, syrups, powders, liquids, injections, and ointments. They have obtained GMP approvals from regulatory bodies in the EU, North America, and other regions, demonstrating their commitment to quality and compliance. The company's global presence extends to key regions like North America, Asia, and Africa, solidifying their position as a trusted partner in the pharmaceutical industry.

Manufacturer usually replies in 30 days

ciprofibrate

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Brazil
GMP approvals
ANVISA
Manufacturer #34253

Established in 1966, this Brazilian pharmaceutical manufacturer is among the top five pharmaceutical corporations in the country. As a CTD dossier owner and manufacturer, it ensures compliance with stringent international quality standards. The company operates advanced production lines adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed in multiple countries worldwide.

Manufacturer usually replies in 78 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Popular Searches

Amoxicillin manufacturers Atorvastatin manufacturers Benzocaine manufacturers Calcium carbonate manufacturers Cloperastine fendizoate manufacturers Gabapentin manufacturers Hyaluronic acid manufacturers Ibuprofen manufacturers Ivermectin manufacturers Levothyroxine manufacturers Lisinopril manufacturers Losartan manufacturers Magnesium manufacturers Melatonin manufacturers Metformin manufacturers Methotrexate manufacturers Metoprolol manufacturers Omeprazole manufacturers Paracetamol manufacturers Prednisone manufacturers Pregabalin manufacturers Semaglutide manufacturers Testosterone enanthate manufacturers Vitamin B12 manufacturers

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.